Ultragenyx Pharmaceutical
(NASDAQ:RARE)
$43.38
-0.73[-1.65%]
At close: Apr 18
$43.38
0[0.00%]
After Hours: 4:00PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Ultragenyx Pharmaceutical Stock (NASDAQ:RARE), Quotes and News Summary

Ultragenyx Pharmaceutical Stock (NASDAQ: RARE) stock price, news, charts, stock research, profile.

Open$44.100
Close$43.380
Volume / Avg.768.249K / 739.245K
Day Range43.320 - 44.800
52 Wk Range31.520 - 54.980
Market Cap$3.572B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
38
Short Interest
4.95%
Days to Cover7.08

Recent News

S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&P 500 also fell, dropping, 1.14% to 5,065.04.
Avi Kapoor
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Avi Kapoor
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&P 500 also rose, gaining, 0.26% to 5,136.94.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
2
Jan
4
1
Feb
1
Mar
1
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Ultragenyx Pharmaceutical Inc.
Sector
Health Care
Industry
Biotechnology
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, dev...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RARE
IMVT

FAQ

Q

How do I buy Ultragenyx Pharmaceutical (RARE) stock?

A

You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ: RARE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ultragenyx Pharmaceutical's (RARE) competitors?

A

Other companies in Ultragenyx Pharmaceutical’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).

Q

What is the target price for Ultragenyx Pharmaceutical (RARE) stock?

A

The latest price target for Ultragenyx Pharmaceutical (NASDAQ: RARE) was reported by Wedbush on Wednesday, April 17, 2024. The analyst firm set a price target for 48.00 expecting RARE to rise to within 12 months (a possible 10.65% upside). 26 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ultragenyx Pharmaceutical (RARE)?

A

The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $43.38 last updated April 18, 2024 at 4:00 PM EDT.

Q

Does Ultragenyx Pharmaceutical (RARE) pay a dividend?

A

There are no upcoming dividends for Ultragenyx Pharmaceutical.

Q

When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?

A

Ultragenyx Pharmaceutical’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Ultragenyx Pharmaceutical (RARE) going to split?

A

There is no upcoming split for Ultragenyx Pharmaceutical.

Q

What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?

A

Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch